Revolade receives positive opinion in Europe

SmPC updated with details of new paediatric indication: “Revolade is indicated for chronic immune thrombocytopenic purpura patients aged 1

Revolade space ELTROMBOPAG Source, S100 HSD Public Body System, BLOOD AND BLOOD FORMING ORGANS > ANTIHEMORRHAGICS > VITAMIN K AND OTHER HEMOSTATICS Note

revolade Revolade Tablet 25 mg is a product of Novartis Ltd Its generic name is Eltrombopag Olamine

revolade The use of REVOLADE to increase and maintain the platelet count prior to and throughout antiviral treatment of HCV infection gives patients a better opportunity